Three-year Effectiveness and Safety of Vedolizumab for IBD Three-year Effectiveness and Safety of Vedolizumab for IBD
This study examined the effectiveness and safety of long-term vedolizumab maintenance therapy in patients with moderate-to-severe active ulcerative colitis and Crohn ' s disease.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 12, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Adalimumab in tight-control approach cost effective in Crohn's
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 31, 2019 Category: Drugs & Pharmacology Source Type: news

Mesenchymal-Stromal-Cell Therapy Effective Long-Term for Crohn's Disease Perianal Fistulas Mesenchymal-Stromal-Cell Therapy Effective Long-Term for Crohn's Disease Perianal Fistulas
Most patients with Crohn ' s disease whose perianal fistulas close after allogeneic bone marrow-derived mesenchymal stromal cell (bmMSC) therapy remain fistula-free four years later, researchers from the Netherlands report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 30, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Etanercept Tx for Autoimmune Disease May Up Risk for IBD
MONDAY, July 15, 2019 -- Patients with autoimmune diseases have an increased risk for being diagnosed with Crohn disease (CD) or ulcerative colitis (UC) while under treatment with etanercept, according to a study published online July 2 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 15, 2019 Category: Pharmaceuticals Source Type: news

Gut virus 'older than humanity' could be useful for Crohn's and diabetes medicine
The virus, nicknamed crAssphage, doesn't cause disease but can attack bacteria. Researchers at San Diego State University said it likely evolved over millions of years to become normal in the gut. (Source: the Mail online | Health)
Source: the Mail online | Health - July 10, 2019 Category: Consumer Health News Source Type: news